Lipigon Pharmaceuticals AB
LPGO | FN
Overview
Corporate Details
- ISIN(s):
- SE0015382072
- LEI:
- 549300XPO40YR12SLY87
- Country:
- Sweden
- Address:
- Tvistevägen 48 C, 907 36 Umeå
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Lipigon Pharmaceuticals AB specializes in therapies for lipid-related diseases. Their research focuses on cardiovascular and metabolic disorders.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-12-16 | Johan Living | Other | Buy | 260,000 | 51,688.00 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
OSE Immunotherapeutics | France | OSE | |
|
Ovoca Bio Plc | Ireland | OVXA | |
|
Oxford Biomedica PLC | United Kingdom | OXB | |
|
OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC | United Kingdom | OCTHF | |
|
Oxurion NV | Belgium | OXUR | |
|
PCI Biotech Holding | Norway | PCIB | |
|
Pentixapharm Holding AG | Germany | PTP | |
|
Perpetua Medical AB | Sweden | PERP | |
|
PharmaLundensis AB | Sweden | PHAL | |
|
Pharma Mar S.A. | Spain | PHM |